REGISTERED NUMBER: SC432222 (Scotland)

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2025

FOR

RESOLVE MEDICOLEGAL LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mr M Broadbent

Mr R A E Clayton

Mrs C F Provan

Mr R L Carter

REGISTERED OFFICE:

The Hub

3 Earl Haig Road

Glasgow

Scotland

G52 4JU

REGISTERED NUMBER:

SC432222 (Scotland)

FIXED ASSETS

Tangible assets

4

15,786

15,927

Investments

5

15,035

35

30,821

15,962

CURRENT ASSETS

Debtors

6

527,714

523,902

Cash at bank

426,619

145,264

954,333

669,166

CREDITORS

Amounts falling due within one year

7

229,335

162,037

NET CURRENT ASSETS

724,998

507,129

TOTAL ASSETS LESS CURRENT LIABILITIES

755,819

523,091

PROVISIONS FOR LIABILITIES

3,283

3,318

NET ASSETS

752,536

519,773

CAPITAL AND RESERVES

Called up share capital

8

110

110

Share premium

99,990

99,990

Retained earnings

652,436

419,673

SHAREHOLDERS' FUNDS

752,536

519,773

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 22 December 2025 and were signed on its behalf by:

Mr M Broadbent - Director

1.	STATUTORY INFORMATION

Resolve Medicolegal Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

RELATED PARTY EXEMPTION

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

TURNOVER

The turnover shown in the profit and loss account represents amount earned during the year and is recognised when the company obtains the right to consideration.

TANGIBLE FIXED ASSETS

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Improvements to property

-

20% on cost

Fixtures and fittings

-

15% on reducing balance

All fixed assets are initially recorded at cost.

INVESTMENTS IN SUBSIDIARIES

Investments in subsidiary undertakings are recognised at cost.

TAXATION

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 18 (2024 - 17 ) .

4.	TANGIBLE FIXED ASSETS

Improvements

Fixtures

to

and

property

fittings

Totals

£

£

£

COST

At 1 October 2024

20,346

37,585

57,931

Additions

-

2,645

2,645

At 30 September 2025

20,346

40,230

60,576

DEPRECIATION

At 1 October 2024

20,346

21,658

42,004

Charge for year

-

2,786

2,786

At 30 September 2025

20,346

24,444

44,790

NET BOOK VALUE

At 30 September 2025

-

15,786

15,786

At 30 September 2024

-

15,927

15,927

5.	FIXED ASSET INVESTMENTS

Shares in

group

Other

undertakings

investments

Totals

£

£

£

COST

At 1 October 2024

35

-

35

Resolve Hub Limited shares

-

15,000

15,000

At 30 September 2025

35

15,000

15,035

NET BOOK VALUE

At 30 September 2025

35

15,000

15,035

At 30 September 2024

35

-

35

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Trade debtors

125,677

121,673

Amounts owed by associates

395,887

395,887

Directors' current accounts

1,000

-

Prepayments and accrued income

5,150

6,342

527,714

523,902

7.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025

2024

£

£

Tax

111,085

68,232

VAT

73,857

54,231

Accrued expenses

44,393

39,574

229,335

162,037

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2025

2024

value:

£

£

100

Ordinary

£1

110

110

9.	RELATED PARTY DISCLOSURES

Throughout the year the company paid £18,000 (2024 - £18,000) to Broadbent Legal Services Limited, a company in which Mr Broadbent is a Director and Shareholder, for Management Consultancy. The balance owing as at the balance sheet date was £Nil (2024 - £Nil).

Throughout the year the company paid £2,000 (2024 - £6,000) to Simpsons Orthopaedics Limited, a company in which Mr Simpson is a Director and Shareholder, for Management Consultancy.. As of February 2025 Simpson Orthopaedics ceased to be a Director.

Throughout the year the company paid £2,500 (2024 - £6,000) to Mr D Donaldson for Management Consultancy. As of February 2025, Mr D Donaldson ceased to be a Director,.

Throughout the year the company paid £6,000 (2024 - £6,000) to Clayton Medical, a company in which Mr Clayton is a Director and Shareholder, for Management Consultancy. The balance owing as at the balance sheet date was £Nil (2024 - £Nil).

As of April 2025, the company paid £3,500.00 to Mr R Carter for Management Consultancy. The balance owing as at the balance sheet date was £Nil.